Data for: Current Off-Label Pharmacotherapeutics in the Management of Novel Coronavirus Disease (Covid-19)

Coronavirus disease 2019 (COVID-19) is a respiratory tract infection
caused by a newly emergent coronavirus, Severe acute respiratory
syndrome SARS-CoV-2, that was first recognized in Wuhan, China, in
December 2019. There are no FDA- approved therapeutics or drugs
to treat, cure or prevent COVID-19. Some reported case studies
indicated the significance of Chloroquine use in mild cases and
Lopinavir and Ritonavir in severe cases of COVID-19 respectively.
Indian Council of Medical Research, India issued a protocol which is
to be implemented along with the WHO guidelines on clinical
management of mild and severe acute respiratory infection when
COVID-19 infection is suspected in Indian patients as a restricted
public health emergency use.